Notably, while PROTACs can alter the existing pathological phenotype of AD, they cannot reverse the damage that has already occurred, particularly in addressing the genetic mutations associated with FAD (Fig
56,57 However, obesity is recognized as a chronic, progressive, and relapsing disease, suggesting that long-term or even indefinite treatment may be necessary for many patients
Si los efectos se intensifican, ajustamos el plan de forma segura
Cimmino et al., 2024)
And even as GLP-1 drugs like Ozempic and Wegovy gain in popularity, scientists all over the world are looking for even more advanced drugs to address diabetes and weight loss
- Melanotan-2 + GLP-1 agonists: MT-2 raises blood pressure and heart rate